Sudden cardiac death and polymorphism of genes-candidates of cardiovascular diseases

Kardiologiya

Volumn 49, Issue 4, 2009, Pages 52-57

  Voevoda, M I ^a   Kulikov, I V ^a   Maximov, V N ^a   Malyutina, S K ^a   Shakhtshneider, E V ^a   Kulishova, L M ^a   Novoselov, V P ^a   Romashchenko, A G ^a  

^a Research Institute for Terapy   (Russian Federation)

Author keywords

Adrenoreceptors; CPIIb IIIa genes; Gene candidates of cardiovascular diseases; Polymorphisms of ACE; Population study; Sudden cardiac death

Indexed keywords

ADRENERGIC RECEPTOR; DIPEPTIDYL CARBOXYPEPTIDASE; DNA; FIBRINOGEN RECEPTOR;

ADULT; ARTICLE; CADAVER; CARDIOVASCULAR DISEASE; COMPARATIVE STUDY; GENE FREQUENCY; GENETIC POLYMORPHISM; GENETIC PREDISPOSITION; GENETICS; GENOTYPE; HUMAN; INCIDENCE; MALE; METABOLISM; MIDDLE AGED; MORTALITY; PROGNOSIS; RETROSPECTIVE STUDY; RUSSIAN FEDERATION; SUDDEN DEATH;

ADULT; CADAVER; CARDIOVASCULAR DISEASES; DEATH, SUDDEN, CARDIAC; DNA; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; INCIDENCE; MALE; MIDDLE AGED; PEPTIDYL-DIPEPTIDASE A; PLATELET GLYCOPROTEIN GPIIB-IIIA COMPLEX; POLYMORPHISM, GENETIC; PROGNOSIS; RECEPTORS, ADRENERGIC; RETROSPECTIVE STUDIES; SIBERIA;

EID: 67649388370     PISSN: 00229040     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Schwartz P.J., La Rovere M.T., Vanoli E. Autonomic nervous system and sudden cardiac death. Circulation 1992; 85 (SUPPL. 1):177-191.
2. Brugada R. Role of molecular biology in identifying individuals at risk for sudden cardiac death. Am J Cardiol 2000; 86(9A):28K-33K.
3. MONICA Monograph and Multimedia Sourcebook. World's largest study of heart disease, stroke, risk factors, and population trends 1979-2002. Edited by Hugh Tunstall - Pedoe (with 64 other contributors for the WHO MONICA Project). Geneva: WHO 2003; 237.
4. Lindpalntner K., Pfeffer MA, Kreutz R. et al. A prospective evaluation of an angiotensin-converting enzyme gene polymorphism and the risk of ischemic heart disease. N Engl J Med 1995; 332: 706-711.
5. 1- Adrenoceptor gene variations: a role in idiopathic dilated cardiomyopathy? J Mol Med 2000; 78: 87-93. (Pubitemid 30201931)
6. Newman P.J., Derbes R.S., Aster R.H. The human platelet alloantigens, P1A1 and P1A2, are associated with a leucine33/proline33 amino acid polymorphism in membrane glycoprotein IIIa, and are distinguishable by DNA typing. J Clin Invest 1989; 83: 1778-1781. (Pubitemid 19124140)
7. Snapir A., Heinonen P., Tuomainen T.P. et al. An insertion/deletion polymorphism in the alpha2B-adrenergic receptor gene is a novel genetic risk factor for acute coronary events. J Am Coll Cardiol 2001; 37: 1516-1522.
8. Zaykin D.V., Pudovkln A.I. 2 program to estimate significans of CHI-2 values using pseudoprobability tests. J Heredity 1993; 84: 152-156.
9. Mikkelsson J., Perola M., Lalppala P. et al. Glycoprotein Ilia P1(A1/A2) polymorphism and sudden cardiac death. J Am Coll Cardiol 2000; 36: 1317-1323.
10. Sperr W.R., Huber K., Roden M. et al. Inherited Platelet Glycoprotein Polymorphisms and a Risk for Coronary Heart Disease in Young Central Europeans Thrombosis Res 1998; 90: 117-123.
11. Bojesen S.E., Juul K., Schnohr P. et al. Platelet glycoprotein IIb/IIIa PI(A2)/ P1(A2) homozygosity associated with risk of ischemic cardiovascular disease and myocardial infarction in young men: the Copenhagen City Heart Study. Copenhagen City Heart Study. J Am Coll Cardiol 2003; 42: 661-667.
12. Borjesson M., Magnusson Y., Hjalmarson A., Andersson B. A novel polymorphism in the gene coding for the beta(1)-adrenergic receptor associated with survival in patients with heart failure. Eur Heart J 2000; 21: 1853-1858.
13. Hodach R.J., Hodach A.E., Fallon J.F. et al. The role of beta-adrenergic activity in the production of cardiac and aortic arch anomalies in chick embryos. Teratology 1975; 12: 33-45.
14. Paavonen K.J., Swan H., Piippo K. et al. Beta 1-Adrenergic receptor polymorphisms, QTc interval and occurrence of symptoms in type 1 of long QT syndrome. Int J Cardiol 2006; 118: 197-202. (Pubitemid 46601647)
15. Wilk J.B., Myers R.H., Pankow J.S. et al. Adrenergic receptor polymorphisms associated with resting heart rate: the HyperGEN Study. Ann Hum Genet 2006; 70(Part 5):566-573. (Pubitemid 44173368)
16. Kanki H., Yang P., Xie H. G. et al. Polymorphisms in beta-adrenergic receptor genes in the acquired long QT syndrome. J Cardiovasc Electrophysiol 2002; 13: 252-256. (Pubitemid 34259209)
17. Tanriverdi H., Evrengul H, Tanriverdi S. et al. Improved endothelium dependent vasodilation in endurance athletes and its relation with ACE I/D polymorphism. Ore J 2005; 69: 1105-1110. (Pubitemid 41603100)
18. Jeron A., Hengstenberg C, Engel S. et al. The D-allele of the ACE polymorphism is related to increased QT dispersion in 609 patients after myocardial infarction. Eur Heart J 2001; 22: 663-668. (Pubitemid 32622426)
19. McNamara D.U., Holubkov R., Janosko K. et al. Pharmacogenetic interactions between beta-blocker therapy and the angiotensin-converting enzyme deletion polymorphism in patients with congestive heart failure. Circulation 2001; 103: 1644-1648. (Pubitemid 32246611)
20. Puljevic D., Smaceli A., Durakovlc Z., Goldner V. Effects of postmyocardial infarction scar size, cardiac function, and severity of coronary artery disease on QT interval dispersion as a risk factor for complex ventricular arrhythmia. Pacing Clin Electrophysiol 1998; 21: 1508-1516. (Pubitemid 28374567)
21. Stoletniy L.N., Pal S.M., Platt M.L. et al. QT Dispersion as a Noninvasive Predictor of Inducible Ventricular Tachycardia. Eur Heart J 1997; 18: 200.
22. Schachter F., Faure-Delanef L, Guenot F. et al. Genetic associations with human longevity at the APOE and ACE loci. Nature Genetics 1994; 6: 29-32. (Pubitemid 24191909)
23. Belmin J., Levy B.I., Michel J.B. Changes in the renin-angiotensin- aldosterone axis in later life. Drugs Aging 1994; 5: 391-400. (Pubitemid 2157457)